Royal Philips Electronics has taken an 80% stake in a joint venture with SHL TeleMedicine to develop new markets for cardiology telemedicine products and services across Europe. The goal is to establish medical call centers and remote
Royal Philips Electronics has taken an 80% stake in a joint venture with SHL TeleMedicine to develop new markets for cardiology telemedicine products and services across Europe. The goal is to establish medical call centers and remote monitoring services for people with cardiac disease. The venture is headquartered in the Netherlands and managed by a joint Philips/SHL team. SHL, an Israeli provider of personal telemedicine systems and call center services, has the option of increasing its stake to 35% in the future. The company claims more than 55,000 subscribers to its services in Israel and already oversees operations in the U.K., Portugal, and Croatia through similar joint-venture arrangements with other partners.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.